Gustatory Modulators Among a Sample of Depressed Egyptian Adults Under Anti-depressants Therapy
NCT04923425 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2021-06-16
Summary
Identify possible modulators for developing gustatory dysfunction among a sample of depressed Egyptian adults (age from 20 to 50 years old) under anti-depressants therapy ( for at least 3 months) using a questionnaire ( appendix) with a binary measuring unit (yes/no).
Conditions
- Taste Disorders
Sponsors & Collaborators
-
Cairo University
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-02-22
- Primary Completion
- 2020-08-08
- Completion
- 2020-10-07
Countries
- Egypt
Study Locations
More Related Trials
-
A Study of HS-10353 in Adult Participants With Major Depressive Disorder
NCT05938179 ·Status: UNKNOWN ·Phase: PHASE2
-
Effects of Nutrients Supplementation in Antidepressant Treated Depressive Disorder Patients
NCT04179006 ·Status: UNKNOWN ·Phase: NA
-
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
NCT07276997 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder (AMDD)
NCT00759395 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe Depression
NCT01814085 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy
NCT05550532 ·Status: COMPLETED ·Phase: PHASE3
-
To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride Tablets
NCT00913822 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-061)
NCT00035295 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Antidepressant on Postsynaptic Signal Transduction in Serotonergic System of Depressed Patients
NCT01352572 ·Status: UNKNOWN ·Phase: NA
-
Hormone and Sleep Response to Antidepressant Treatment in Adolescents and Adults With Depression
NCT00106197 ·Status: UNKNOWN ·Phase: PHASE4
-
Outcome Following Antidepressant Treatment on Possible Endo-Phenotypes for Major Depression
NCT00386841 ·Status: COMPLETED ·Phase: PHASE4
-
Flexible Dose Titration Add-on Study to Treat Major Depressive Disorder
NCT00593879 ·Status: COMPLETED ·Phase: PHASE2
-
NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorder
NCT05136755 ·Status: RECRUITING ·Phase: PHASE2
-
Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder
NCT05536414 ·Status: COMPLETED ·Phase: PHASE2
-
LSD Therapy for Persons Suffering From Major Depression
NCT03866252 ·Status: COMPLETED ·Phase: PHASE2
-
Beta-CIT-SPECT and Neurophysiology in Depression
NCT00145132 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)
NCT01111552 ·Status: TERMINATED ·Phase: PHASE3
-
Investigation of Antidepressant Efficacy of Oral Ketamine Treatment
NCT02992496 ·Status: UNKNOWN ·Phase: PHASE2
-
The Antidepressant Efficacy of the Anticholinergic Scopolamine
NCT00369915 ·Status: TERMINATED ·Phase: PHASE2
-
Antidepressant Effects of the Glycine Receptor Antagonist AV-101 (4-chlorokynurenine) in Major Depressive Disorder
NCT02484456 ·Status: COMPLETED ·Phase: PHASE2
-
Metyrapone as Additive Treatment in Major Depression
NCT00125554 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-060)(COMPLETED)
NCT00035282 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of Once-Weekly Oral NBI-1065846 in the Treatment of Anhedonia in MDD
NCT05165394 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Plasma Concentration Changes Between Two Types of Tablets of FK949E Administration to Patients With Major Depressive Disorder
NCT01919008 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Serotonin Agonist Citalopram on Multimodal Esophageal Stimulation in Healthy Volunteers
NCT04355455 ·Status: COMPLETED ·Phase: NA